BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17302609)

  • 21. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
    Redondo P; Lloret P; Idoate M; Inoges S
    Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
    Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
    Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes.
    Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O
    Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
    Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
    Thies A; Mangold U; Moll I; Schumacher U
    J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular markers associated to prognosis of melanoma].
    Heenen M; Laporte M
    Ann Dermatol Venereol; 2003 Nov; 130(11):1025-31. PubMed ID: 14724537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent intrathoracic thymomas: potential prognostic importance of cell-cycle protein expression.
    Mineo TC; Ambrogi V; Baldi A; Pompeo E; Mineo D
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):40-5. PubMed ID: 19577054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of P53 protein in cutaneous melanoma].
    Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M
    Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
    Alonso SR; Tracey L; Ortiz P; Pérez-Gómez B; Palacios J; Pollán M; Linares J; Serrano S; Sáez-Castillo AI; Sánchez L; Pajares R; Sánchez-Aguilera A; Artiga MJ; Piris MA; Rodríguez-Peralto JL
    Cancer Res; 2007 Apr; 67(7):3450-60. PubMed ID: 17409456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER3 is a determinant for poor prognosis in melanoma.
    Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
    Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
    Murtas D; Piras F; Minerba L; Ugalde J; Floris C; Maxia C; Demurtas P; Perra MT; Sirigu P
    Oncol Rep; 2010 Feb; 23(2):329-35. PubMed ID: 20043092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
    Depasquale I; Thompson WD
    Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.